Is this a piece of news regarding world politics, sports, business, or science and technology?
Big setback for Merck cholesterol drug High doses of Zocor provide no benefits in preventing new problems in heart attack patients: study. MUNICH (Reuters) - Merck #39;s anti-cholesterol drug Zocor suffered a setback after a major study found high  
